You appear to be offline. Some data may be unavailable until your connection is restored.
Description
Danaher Corporation is a global science and technology company that designs, manufactures, and markets instruments, consumables, software and services for the biotechnology, life‑sciences and clinical diagnostics markets. Its portfolio includes bioprocessing systems, analytical instruments such as mass spectrometers and microscopes, molecular diagnostic platforms, and related reagents and workflow solutions sold to pharmaceutical firms, research institutions, hospitals and commercial laboratories. Operating primarily in the healthcare and industrial technology sectors, Danaher is recognized for its continuous‑improvement framework, the Danaher Business System, which drives operational efficiency and supports a high proportion of recurring revenue. The company holds a leading “pick‑and‑shovel” position in the biotech supply chain, with a diversified set of businesses and a history of strategic acquisitions that reinforce its market leadership.
Quarterly EarningsQuarterly earnings results, including reported and estimated earnings per share (EPS), for the most recent fiscal quarters.Surprise compares reported EPS with the prior estimate.
| Quarter | DateReport date | EPSReported EPS |
|---|---|---|
| Q3 FY26 | Oct 21, 2026 | — |
| Q2 FY26 | Jul 21, 2026 | $1.94 |
| Q1 FY26 | Apr 21, 2026 | $2.06 |
| Q4 FY25 | Jan 28, 2026 | $2.23 |
| Q3 FY25 | Oct 21, 2025 | $1.89 |
Stay ahead of DHR earnings
Get reminders ahead of DHR's next earnings report, so you always know when results are coming.